King Pharmaceuticals Mergers and Acquisitions Summary

Life ScienceCompany

King Pharmaceuticals has acquired 2 companies of its own.

King Pharmaceuticals’ largest acquisition to date was in 2008, when it acquired Alpharma Pharmaceuticals for $16.0B. King Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to King Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 2

King Pharmaceuticals LLC

501 Fifth Street,
Bristol, Tennessee 37620
United States,
(423) 989-8000

King Pharmaceuticals LLC is a vertically integrated branded pharmaceutical company. King seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital. King's wholly owned subsidiary, Alpharma, LLC, is also a leader in the development, registration, manufacture and marketing of pharmaceutical products for food producing animals.

M&A Summary

Buy vs Sell

Year ≤ '03 '04 '05 '06 '07 '08 T
Buy (0.4/yr) # - - - - - 2 2
vol $17.6B $17.6B
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Alpharma Pharmaceuticals Inc. 2008-12-29 16.0B USD Add-on Acquisition
Piscataway, New Jersey
Alpharma, Inc. 2008-11-21 1.6B USD Add-on Acquisition
Piscataway, New Jersey
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 17.6B (100%) - -
Total 2 $17.6B - -

By Geo

State/Country Buy Value Sell Value
United States 2 17.6B - -
  New Jersey 2 17.6B - -
Total 2 $17.6B - -

Top M&A Advisors

Financial Deals
Credit Suisse Investment Banking
Legal Deals
Dewey & LeBoeuf LLP

Deal Values

buy # Total
> $1B 2 $17.6B
TOTAL $17.6B
Largest Alpharma Pharmaceuticals Inc.
$16.0B (2008-12-29)

 Subscribe to unlock this and 181,472
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.3K Private Equity Firms
  • 172K M&A Transactions
  • 177K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 63K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.